Menu Search
Equities

Serstech AB

  • Add to watchlist
  • Add to portfolio
  • Add an alert
284:FRA

Serstech AB

Actions
  • Price (EUR)0.0304
  • Today's Change-0.002 / -6.46%
  • Shares traded5.00k
  • 1 Year change-63.72%
  • Beta0.6481
Data delayed at least 15 minutes, as of Feb 10 2026 07:07 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Serstech AB is a Sweden-based developer of micro-spectrometers. The Company's products split light into various wavelengths to identify drugs, and explosive and hazardous materials. The Company offers micro-spectrometer chips, which are optical components integrated on chips for the measurement of color, absorption, fluorescence, and Raman spectra; micro-spectrometer-boards; surface enhanced Raman spectroscopy surfaces that provide various orders of magnitude amplification in independent tests; and custom spectrometers. The Company offers its products for security, defense, industry, med-tech, and clean-tech application areas. It serves customers such as police, rescue, customs, and defense officers to identify powders, pills, and fluids.

  • Revenue in SEK (TTM)45.55m
  • Net income in SEK-22.48m
  • Incorporated2006
  • Employees26.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.